Oxaliplatin-induced Sudden Hearing Loss in a Patient with Pancreatic Cancer / 대한소화기학회지
The Korean Journal of Gastroenterology
;
: 261-264, 2020.
Article
in English
| WPRIM
| ID: wpr-834094
ABSTRACT
Oxaliplatin is a new generation of platinum derivatives used frequently to treat solid organ malignancies, including colorectal and ovarian cancer. Recently, an oxaliplatin-based chemotherapeutic regimen was adopted for advanced pancreatic cancer. Although oxaliplatin has extensive therapeutic potential, its use can be limited by significant adverse effects, particularly ototoxicity. This paper reports a rare case of irreversible unilateral hearing loss in a 48-year-old female that developed after the intravenous infusion of oxaliplatin during pancreatic cancer treatment. To the best of the authors’ knowledge, this is the second reported case of oxaliplatin-related ototoxicity in pancreatic cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
The Korean Journal of Gastroenterology
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS